Search results
Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 6 days agoSo they usually pay more attention to companies that are included in major indices. We can see that ...
Bristol-Myers Squibb Co. [BMY] Records 50-Day SMA of $48.20 – Knox Daily
Knox Daily· 1 day agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Bristol< ...
A Guide To The Risks Of Investing In Bristol-Myers Squibb Co.
Knox Daily· 4 days agoIn the...Samuels Theodore R. II bought 8,500 shares. Bristol-Myers Squibb Co. shares valued at $423,385 were divested by the Director...Redburn Atlantic ...
This Unpopular Dividend Stock Is a Buy
The Motley Fool via AOL· 1 day agoHere's why contrarian investors may want to scoop up this unpopular dividend stock right now. Bristol Myers Squibb: A proven value creator ...
1 Stock I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 3 days agoWith a setup like that, there simply isn't much reason to buy shares of this company today. With a payout ratio near 60%, it probably won't need to stop...
Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To...
Benzinga via AOL· 2 days agoA judge in Hawaii has reportedly ordered Bristol Myers Squibb & Co (NYSE:BMY) and Sanofi SA...
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
Zacks via Yahoo Finance· 2 days agoConcurrent with the first-quarter earnings release, Bristol Myers also announced that it is...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga· 2 hours agoVerastem Oncology has established clinical collaborations with Amgen Inc AMGN and Bristol-Myers ...
3 Attractive High Dividend Stocks Yielding Over 5%
TheStreet.com· 7 days agoAs a result, many stocks have lower dividend yields than they did several years ago, due to rising share prices. Truist Financial (TFC) is a financial...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 1 day agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
